Literature DB >> 10609669

Determinants of attrition in a natural history study of Alzheimer disease.

E Koss1, B Peterson, G G Fillenbaum.   

Abstract

The aim of the present study was to identify determinants of attrition in a natural history study of a tertiary care sample of patients with Alzheimer disease (AD) and control subjects. A longitudinal study was performed with 978 patients with AD and 466 control subjects age 50 years and older enrolled at 25 sites of the Consortium to Establish a Registry for Alzheimer's Disease between January 1987 and January 1992; subjects were followed annually for up to 78 months. Both descriptive statistics and polytomous logistic regressions were run to identify determinants of attrition. Of the 1,444 subjects enrolled, 10.5% dropped out after initial evaluation, 31.0% provided at least two waves of data, and 58.4% provided complete follow-up. Inadequate involvement by the site, non-white status, and patient's spouse not enrolled in the study were predictive of dropout; cessation of participation because of death (which may have precluded dropout) predicted continuation in the study. Age, level of education, severity of dementia, and rapidity of progression of disease did not predict dropout. Level-of-site commitment was the most significant determinant of continued participation in this natural history study of AD, followed by white race, and the inclusion of both husband and wife where one is a patient and the other a control subject.

Entities:  

Mesh:

Year:  1999        PMID: 10609669     DOI: 10.1097/00002093-199910000-00006

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  8 in total

1.  Retention of Alzheimer Disease Research Participants.

Authors:  Joshua D Grill; Jimmy Kwon; Merilee A Teylan; Aimee Pierce; Eric D Vidoni; Jeffrey M Burns; Allison Lindauer; Joseph Quinn; Jeff Kaye; Daniel L Gillen; Bin Nan
Journal:  Alzheimer Dis Assoc Disord       Date:  2019 Oct-Dec       Impact factor: 2.703

2.  Demographic and Operational Factors Predicting Study Completion in a Multisite Case-Control Study of Preschool Children.

Authors:  Chyrise B Bradley; Erica N Browne; Aimee A Alexander; Jack Collins; Jamie L Dahm; Carolyn G DiGuiseppi; Susan E Levy; Eric J Moody; Laura A Schieve; Gayle C Windham; Lisa Young; Julie L Daniels
Journal:  Am J Epidemiol       Date:  2018-03-01       Impact factor: 4.897

3.  Challenging Assumptions About African American Participation in Alzheimer Disease Trials.

Authors:  Richard E Kennedy; Gary R Cutter; Guoqiao Wang; Lon S Schneider
Journal:  Am J Geriatr Psychiatry       Date:  2017-04-25       Impact factor: 4.105

4.  Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study.

Authors:  Thomas Polak; Martin J Herrmann; Laura D Müller; Julia B M Zeller; Andrea Katzorke; Matthias Fischer; Fabian Spielmann; Erik Weinmann; Leif Hommers; Martin Lauer; Andreas J Fallgatter; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

5.  Effectiveness of a specific care plan in patients with Alzheimer's disease: cluster randomised trial (PLASA study).

Authors:  Fati Nourhashemi; Sandrine Andrieu; Sophie Gillette-Guyonnet; Bruno Giraudeau; Christelle Cantet; Nicola Coley; Bruno Vellas
Journal:  BMJ       Date:  2010-06-03

6.  Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years.

Authors:  Gerda G Fillenbaum; Gerald van Belle; John C Morris; Richard C Mohs; Suzanne S Mirra; Patricia C Davis; Pierre N Tariot; Jeremy M Silverman; Christopher M Clark; Kathleen A Welsh-Bohmer; Albert Heyman
Journal:  Alzheimers Dement       Date:  2008-03       Impact factor: 21.566

7.  Challenges associated with longitudinal survivorship research: attrition and a novel approach of reenrollment in a 6-year follow-up study of older breast cancer survivors.

Authors:  Kerri M Clough-Gorr; Aliza K Fink; Rebecca A Silliman
Journal:  J Cancer Surviv       Date:  2008-04-17       Impact factor: 4.442

8.  Recruitment and retention of participant and study partner dyads in two multinational Alzheimer's disease registration trials.

Authors:  Olivia M Bernstein; Joshua D Grill; Daniel L Gillen
Journal:  Alzheimers Res Ther       Date:  2021-01-08       Impact factor: 6.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.